Else Nutrition's Q3 revenues at $1.66-million

Ms. Hamutal Yitzhak reports ELSE NUTRITION REPORTS SIGNIFICANT OPERATIONAL TURNAROUND IN Q3 2025 WITH GROSS MARGIN EXPANSION AND COST REDUCTION Else Nutrition Holdings Inc. has released financial results for the 2025 third quarter ended Sept. 30, 2025. The financial statements and MD&A (management discussion and analysis are available on SEDAR under the company's profile. 2025 third quarter financial results: Gross profit margin (GPM) surged to 34 per cent, compared with negative 9 per cent in Q3 2024 and negative 4 per cent in Q2 2025, reflecting successful cost optimization and manufacturing transition; Operating expenses decreased by 68 per cent year over year, totalling $1.15-million in Q3 2025 versus $3.56-million in Q3 2024, driven by disciplined cost management; Operating loss reduced to $580,000 in Q3 2025, compared with $3.72-million in Q3 2024, marking a major milestone in financial sustainability; Revenue remained stable at $1.66-million, slightly down from $1.79-million in Q3 2024 due to temporary out-of-stock issues, which the company is actively addressing; Cash position at quarter-end: $91,000 (including restricted cash); Significant reduction of 46 per cent in trade payables from $2.84-million as of Dec. 31, 2024, to $1.53-million as of Sept. 30, 2025, strengthening the company's ability to manage its debt. "The third quarter represented a period of stabilization, focus and disciplined execution for Else Nutrition," said Hamutal Yitzhak, chief executive officer of Else Nutrition. "We delivered a dramatic improvement in our fundamentals. Our gross margin expansion to 34 per cent and a 68-per-cent reduction in operating expenses demonstrate the effectiveness of our restructuring and cost-control initiatives. With a leaner organization and a materially reduced operation expenses, we are well positioned for sustainable growth and heading towards profitability. "On the regulatory front, we are encouraged by the ongoing modernization of U.S. infant formula standards, which we believe will pave the way for greater innovation in our category. Else is actively preparing for its next clinical phase to advance our plant-based infant formula toward market readiness. We also continue to engage with international partners exploring strategic collaborations across commercial, R&D [research and development], and manufacturing fronts. These discussions reflect the credibility of our brand, the strength of our intellectual property and the increasing recognition of Else as a pioneer in plant-based nutrition. "Over all, we continue to focus on resolving supply chain challenges, expanding our retail and on-line presence, and advancing regulatory milestones for our plant-based infant formula, and these achievements -- together with ongoing discussions with strategic partners -- reinforce our confidence in Else's recovery trajectory. Supported by inventory normalization and strategic initiatives designed to accelerate revenue growth while maintaining cost discipline, we expect continued operational improvements in Q4." Conference call Else Nutrition management plans to host a business update conference call on Monday, Nov. 17, 2025, at 10 a.m. Eastern Time to discuss the company's financial results for the third quarter of 2025 ended Sept. 30, 2025, as well as the company's corporate progress and other developments. The conference call will be available through telephone by dialling toll-free 1-877-407-9219 for U.S. callers or 1-412-652-1274 for international callers. A webcast of the call may be accessed on the investor relations section of the company's website. A webcast replay will be available on the investor relations section of the company's website through Sept. 17, 2026. A telephone replay of the call will be available approximately three hours following the call through Dec. 1, 2025, and can be accessed by dialling 1-877-660-6853 for U.S. callers or 1-201-612-7415 for international callers and entering conference ID 13757060. About Else Nutrition Holdings Inc. Else Nutrition Holdings is a food and nutrition company in the international expansion stage focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its plant-based complete nutrition for toddlers, made of whole foods, almonds, buckwheat and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth. We seek Safe Harbor.